Clinical trial
An Observational Drug Utilization Study of SYCREST^® (Asenapine) in the United Kingdom
NCT01498770 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Drug Utilization Study of SYCREST^® (Asenapine) in the United Kingdom
- Lead sponsor
- Organon and Co
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 1, 2013
- Completion date
- December 21, 2017
- Enrollment
- 42 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.